An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of uncertain source.
Several professionals said the popularity for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Service Response and Content Removal
Based on the social media company, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also found communities with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, glowing reviews and detailed guides for mixing or administering at residence.
Within minutes of entering one group, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Item Information and Costs
Inside these groups, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram said it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially serious health risks”.
